Home » Topics » BioWorld Science, Cancer

BioWorld Science, Cancer
RSS

Wild-type and mutant RET inhibitors identified at Medshine Discovery

May 12, 2020

Dana-Farber Cancer Institute, Voronoi patent wild-type and mutant LRRK2 inhibitors

May 12, 2020

New histone-lysine N-methyltransferase SMYD3 inhibitors identified at Epizyme

May 12, 2020

Array BioPharma discloses new PTPN11 inhibitors

May 12, 2020

Novel peptide-targeted approach improves potency of anticancer drugs

May 12, 2020

FDA approves Lynparza with bevacizumab for HRD-positive advanced ovarian cancer

May 11, 2020

Oncoinvent recruits for phase I study of Radspherin

May 11, 2020

FDA approves Retevmo for advanced RET-driven lung and thyroid cancers

May 11, 2020

Cell competition links hyperinsulinemia to cancer

May 11, 2020

First-in-human results presented for SLC-0111 in advanced solid tumors

May 11, 2020

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 21, 2026.
ALN-5288 lowers tau levels in preclinical models
BioWorld Science
Pathological tau accumulation is a key driver of neurodegeneration in Alzheimer’s disease (AD) and other tauopathies such as progressive supranuclear palsy....
LIT-002 is strong candidate for autism and neuropathic pain
BioWorld Science
Researchers from the University of Strasbourg and the Centre National de la Recherche Scientifique (CNRS) have presented data on LIT-002, a nonpeptide oxytocin...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 21, 2026
Anle-138b reduces mHTT aggregation, improves pathological phenotypes in Huntington’s models
BioWorld Science
Anle-138b (emrusolmin) is a diphenylpyrazole compound that directly interacts with oligomeric species of disease-related aggregating proteins, reducing aggregate...